伯乐生命医学

US · BIO #1479 按市值排名上市于 1970

353.70 -11.12 -3.05%

实时 - 追踪5344个代码 - 心跳于1秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

涨跌不一/平稳

机构持股总比例基本持平。

机构持股

机构持股比例: 88.56% +0.03pp
机构数量: 473
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund60.17%

Private Company16.21%

Hedge Fund5.37%

Public Company5.30%

Individual/Insider4.78%

Government Pension Fund0.87%

Sovereign Wealth Fund0.42%

Insurance Company0.10%

Other6.72%

主要股东截至 2026-09-01

Blue Raven Partners, L.P. 15.18% · 4.06M 股

First Eagle Investment Management, LLC 9.75% · 2.61M 股

BlackRock 6.35% · 1.70M 股

Norman Schwartz 4.58% · 1.23M 股

Dimensional Fund Advisors 3.53% · 944.55K 股

Vanguard Capital Management, LLC 3.52% · 941.38K 股

Capital Research 3.39% · 905.94K 股

Ariel Investments, LLC 3.05% · 816.75K 股

Vanguard Portfolio Management, LLC 3.05% · 816.20K 股

UBS Asset Management 2.72% · 727.22K 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 33次买入 · 17次卖出

姓名	职务	持股比例
Norman Schwartz	Chairperson & CEO	4.58%
Colleen Corey	Executive Vice President of Global Human Resources	0.07%
Michael Crowley	Executive Vice President of Global Commercial Operations	0.03%
Allison Schwartz	Director	0.02%
Roop Lakkaraju	Chief Financial Officer	0.02%
Sedat Evran	Executive Vice President of Global Supply Chain	0.01%
James Barry	Senior Vice President of Global Manufacturing	0.01%
Jonathan DiVincenzo	President	0.01%
Eva Engelhardt	Executive VP & President of the Clinical Diagnostics Group	0.01%
Courtney Enloe	General Counsel	0.01%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-05	Norman Schwartz	Chairperson & CEO	Derivative Exercise and Sale	-4,730	$386.11
2026-09-05	Norman Schwartz	Chairperson & CEO	Derivative Exercise and Retained	+2,834	--
2026-09-05	Roop Lakkaraju	Chief Financial Officer	Derivative Exercise and Sale	-1,341	$386.11
2026-09-05	Roop Lakkaraju	Chief Financial Officer	Derivative Exercise and Retained	+1,565	--
2026-09-05	Eva Engelhardt	Executive VP & President of the Clinical Diagnostics Group	Derivative Exercise and Sale	-854	$386.11
2026-09-05	Eva Engelhardt	Executive VP & President of the Clinical Diagnostics Group	Derivative Exercise and Retained	+1,325	--
2026-09-05	Allison Schwartz	Director	Derivative Exercise and Sale	-116	$386.11
2026-09-05	Allison Schwartz	Director	Derivative Exercise and Retained	+204	--
2026-09-05	James Barry	Senior Vice President of Global Manufacturing	Derivative Exercise and Sale	-839	$386.11
2026-09-05	James Barry	Senior Vice President of Global Manufacturing	Derivative Exercise and Retained	+1,244	--
2026-09-05	Sedat Evran	Executive Vice President of Global Supply Chain	Derivative Exercise and Sale	-606	$386.11
2026-09-05	Sedat Evran	Executive Vice President of Global Supply Chain	Derivative Exercise and Retained	+1,285	--
2026-09-05	Courtney Enloe	General Counsel	Derivative Exercise and Sale	-551	$386.11
2026-09-05	Courtney Enloe	General Counsel	Derivative Exercise and Retained	+902	--
2026-09-04	Jonathan DiVincenzo	President	Derivative Exercise and Sale	-668	$386.11
2026-09-04	Jonathan DiVincenzo	President	Derivative Exercise and Retained	+1,044	--
2026-09-04	Rajat Mehta	Executive Vice President of Global Commercial Operations	Derivative Exercise and Sale	-737	$386.11
2026-09-04	Rajat Mehta	Executive Vice President of Global Commercial Operations	Derivative Exercise and Retained	+1,089	--
2026-09-03	Norman Schwartz	Chairperson & CEO	Other Derivative Acquisition	+17,251	--
2026-09-03	Roop Lakkaraju	Chief Financial Officer	Other Derivative Acquisition	+6,326	--

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。